Ibrutinib has showed clinically meaningful and durable responses in patients with chronic graph-versus-host-disease (cGVHD).
Chase Doyle
Advertisement
Articles by Chase Doyle
A second round of chemotherapy or stem cell transplant for patients with multiple myeloma does not improve PFS or OS compared to the current standard couse of treatment.
Advertisement
Latest Updated Articles
Ibrutinib Shows Promise in Treating GVHD After Stem Cell TransplantFebruary 20th 2017
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer
2
Nursing Guide to Managing Lorlatinib in ALK+ NSCLC: 7-Year CROWN Insights
3
GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival
4
FDA Approves Oral Nilotinib Tablets for Ph+ CML
5